Observational study with no interventions

OTHER2 trials

Sponsors

Nottingham University Hospitals NHS Trust, Replimune Inc.

Conditions

Advanced Solid TumorB12 Deficiency VitaminHepatocellular CarcinomaMelanomaMetastatic MelanomaNeurologic SymptomsNitrous Oxide AbuseParesthesia

Unknown Phase

Neurological Recovery Following NOS-SACD

RecruitingNCT05714917

Nottingham University Hospitals NHS TrustB12 Deficiency Vitamin, Neurologic Symptoms, Nitrous Oxide Abuse +2

Start: 2024-08-19End: 2026-08-19Target: 100Updated: 2025-07-25

A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

RecruitingNCT06887348

Replimune Inc.Advanced Solid Tumor, Hepatocellular Carcinoma, Melanoma +1

Start: 2025-12-12End: 2035-12-31Target: 50Updated: 2026-01-12